The rates of tumor growth inhibition in the xenograft of the GLUT-1 AS-ODN group, LY294002 group, LY294002 plus GLUT-1 AS-ODN group, 10-Gy group, LY294002 plus 10-Gy group, and LY294002 plus GLUT-1 AS-ODN plus 10-Gy group were 37.3%, 3.4%, 50.0%, 7.0%, 67.7%, and 57.8%, respectively. This evidence concerns the gene SLC2A1 and neoplasm.